Aging drug pioneer Calico inks $1 billion extension of AbbVie deal

The seven-year research collaboration, which now will continue into 2025 and oversee clinical trials into 2030, has spun three neurodegenerative and cancer immunotherapy programs into the clinic.

Source: bizjournals.com Health Care News Headlines - July 28, 2021 Category: Health Management Authors: Ron Leuty Source Type: news